Outlook on the Foot and Mouth Disease (FMD) Vaccine Global Market to 2026 - by Animal Type, Vaccine Type, Distribution Channel and Region

Research and Markets
·8 min read

Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The "Foot and Mouth Disease (FMD) Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global foot and mouth disease (FMD) vaccine market grew at a CAGR of around 6% during 2015-2020. The foot and mouth disease (FMD) occurs due to a transboundary, contagious virus that infects cloven-hoofed animals. It primarily affects cattle, such as buffaloes, pigs, sheep, goats, etc., and a few wildlife species, including deer, bison, camelid, antelope, etc. The FMD virus (FMDV) has seven immunologically distinct serotypes, namely O, A, C, SAT1, SAT2, SAT3, and Asia 1. This viral disease exhibits common symptoms in animals, such as blisters on lips and tongue, fever, excessive salivation, anorexia, low meat and milk productivity, etc. Several vaccines, based on aluminum hydroxide, saponin, and oil formulations, are used against FMD contraction.

The high prevalence of FMD along with its socio-economic impact on the international trade of animal products is driving the FMD vaccine market. The growing meat processing industry and the increasing consumption of dairy products are also fueling the need for FMD vaccines. Additionally, the rising demand for high-grade and disease-free meat supply from livestock is further augmenting the market growth. Apart from this, the implementation of mandatory norms regarding cattle rearing is leading to the bulk purchase of vaccines to control FMD outbreaks.

Furthermore, government bodies across the globe are also introducing several awareness programs for protecting endangered wildlife species, such as bison and antelope, against FMD. Rising globalization along with the growing livestock population across both developed and developing markets is also driving the market for FMD vaccines. Furthermore, the increasing presence of veterinary centers providing safe healthcare practices for livestock is also creating a positive impact on the market growth. Looking forward, the publisher expects the global foot and mouth disease (FMD) vaccine market to continue its moderate growth during the next five years.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global foot and mouth disease (fmd) vaccine market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, animal type, vaccine type and distribution channel.

Breakup by Animal Type:

  • Cattle

  • Pig

  • Sheep and Goat

  • Others (buffalo, camels, deer)

Breakup by Vaccine Type:

  • Conventional Vaccines

  • Oil based Vaccines

  • Aluminium Hydroxide/Saponin Based Vaccines

  • Emergency Vaccines

Breakup by Distribution Channel:

  • Government Organizations

  • Distributors/ Pharmacies

  • Private Vet

  • Others

Breakup by Region:

  • Asia Pacific

  • China

  • India

  • Bangladesh

  • Vietnam

  • Korea

  • Others

  • Latin America

  • Brazil

  • Argentina

  • Others

  • Middle East and Africa

  • Nigeria

  • Ethiopia

  • Iran

  • Algeria

  • Others

  • Europe

  • Turkey

  • Georgia

  • Armenia

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agrovet Co., Bayer AG, Biogenesis Bago, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, China Animal Husbandry Group, FGBI "Federal Centre for Animal Health, Indian Immunologicals Limited, Limor de Colombia, Merck & Co. Inc, Vecol S.A. and VETAL Animal Health Products Company.

Key Questions Answered in This Report:

  • How has the global foot and mouth disease (FMD) market performed so far and how will it perform in the coming years?

  • What has been the impact of COVID-19 on the global foot and mouth disease (FMD) market?

  • What are the key regional markets?

  • What is the breakup of the market based on the animal type?

  • What is the breakup of the market based on the vaccine type?

  • What is the breakup of the market based on the distribution channel?

  • What are the various stages in the value chain of the industry?

  • What are the key driving factors and challenges in the industry?

  • What is the structure of the global foot and mouth disease (FMD) market and who are the key players?

  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Foot and Mouth Disease (FMD) Vaccine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Animal Type
6.1 Cattle
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Pig
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Sheep and Goat
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast

7 Market Breakup by Vaccine Type
7.1 Conventional Vaccines
7.1.1 Market Trends
7.1.2 Oil based Vaccines
7.1.2.1 Market Trends
7.1.2.2 Market Forecast
7.1.3 Aluminium Hydroxide/Saponin Based Vaccines
7.1.3.1 Market Trends
7.1.3.2 Market Forecast
7.1.4 Market Forecast
7.2 Emergency Vaccines
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Distribution Channel
8.1 Government Organizations
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Distributors/Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Private Vet
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Region
9.1 Asia Pacific
9.1.1 China
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 India
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.1.3 Bangladesh
9.1.3.1 Market Trends
9.1.3.2 Market Forecast
9.1.4 Vietnam
9.1.4.1 Market Trends
9.1.4.2 Market Forecast
9.1.5 Korea
9.1.5.1 Market Trends
9.1.5.2 Market Forecast
9.1.6 Others
9.1.6.1 Market Trends
9.1.6.2 Market Forecast
9.2 Latin America
9.2.1 Brazil
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Argentina
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 Others
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.3 Middle East and Africa
9.3.1 Nigeria
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 Ethiopia
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 Iran
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Algeria
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Others
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.4 Europe
9.4.1 Turkey
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Georgia
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Armenia
9.4.3.1 Market Trends
9.4.3.2 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porter's Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Agrovet Co.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Bayer AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Biogenesis Bago
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Boehringer Ingelheim International GmbH
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Brilliant Bio Pharma Private Limited
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 China Animal Husbandry Group
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 FGBI "Federal Centre for Animal Health
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Indian Immunologicals Limited
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Limor de Colombia
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Merck & Co. Inc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Vecol S.A.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 VETAL Animal Health Products Company
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio

For more information about this report visit https://www.researchandmarkets.com/r/d84ajt

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900